A Phase 3 clinical trial validating the potency and safety of an innovative, extra‐long‐acting interferon in chronic hepatitis C
暂无分享,去创建一个
H. Kuo | C.-H. Chen | Jyh-Jou Chen | Xinmin Zhou | D. Jun | J. Shang | W. Chuang | W. Xie | S. Dang | A. Qin | G. Lo | Ching-chu Lo | Wen-Hua Zhang | Chi-yi Chen | Yi-Wen Huang | Chan-Yen Tsai | Li-ying Zhu | Xiaorong Mao | Pei‐Jer Chen | Guo-Qiang Zhang | K. Tseng | Ting‐Fang Wang | Hsin‐Hui Lai